| 创新性药物研发失败原因的探讨 |
| |
| 引用本文： | 杨志敏,冯毅. 创新性药物研发失败原因的探讨[J]. 中国新药杂志, 2010, 0(1) |
| |
| 作者姓名： | 杨志敏 冯毅 |
| |
| 作者单位： | 国家食品药品监督管理局药品审评中心; |
| |
| 摘 要： | 通过对近年来在我国申报的创新性化学药品申请项目的审评情况以及不批准的原因进行系统分析,探求导致创新药研发失败的主要因素。分析结果显示,在11.4%不批准的创新性药品申请中,41%为临床定位不合理,29%为临床前安全性结果不支持临床方案。
|
| 关 键 词： | 创新性药物 研发 失败 |
Analysis of failures in the research and development of new drugs |
| |
| YANG Zhi-min,FENG Yi. Analysis of failures in the research and development of new drugs[J]. Chinese Journal of New Drugs, 2010, 0(1) |
| |
| Authors: | YANG Zhi-min FENG Yi |
| |
| Affiliation: | YANG Zhi-min,FENG Yi(Center for Drug Evaluation,State Food , Drug Administration,Beijing 100038,China) |
| |
| Abstract: | We systemically analyzed the review results and failed reasons in applications for investigational new drugs.The aim of this paper was to analyze the main factors that led to failures in the research and development of new drugs.The results have shown that 11.4% applications were not approved by SFDA,in which 41% applications had no suitable and good clinical advantages,29% applications had no adequate and good preclinical safety data to support the clinical trials. |
| |
| Keywords: | investigational new drug research and development failure |
| 本文献已被 CNKI 等数据库收录！ |
|
